NPs Basic Information

Name
Oxohygrolidin
Molecular Formula C34H54O7
IUPAC Name*
(3E,5E,7R,8S,9S,11E,13E,15S,16R)-16-[(E,2S,3R,4S,8R,9R)-3,9-dihydroxy-4,8-dimethyl-5-oxoundec-6-en-2-yl]-8-hydroxy-15-methoxy-3,5,7,9,11-pentamethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one
SMILES
CC[C@H]([C@H](C)/C=C/C(=O)[C@@H](C)[C@@H]([C@H](C)[C@@H]1[C@H](/C=C/C=C(/C[C@@H]([C@@H]([C@@H](/C=C(/C=C(/C(=O)O1)\C)\C)C)O)C)\C)OC)O)O
InChI
InChI=1S/C34H54O7/c1-11-28(35)22(4)15-16-29(36)26(8)32(38)27(9)33-30(40-10)14-12-13-20(2)17-23(5)31(37)24(6)18-21(3)19-25(7)34(39)41-33/h12-16,18-19,22-24,26-28,30-33,35,37-38H,11,17H2,1-10H3/b14-12+,16-15+,20-13+,21-18+,25-19+/t22-,23+,24-,26-,27+,28-,30+,31+,32+,33-/m1/s1
InChIKey
HBTGJJXCZRLXJW-YMGFNHCLSA-N
Synonyms
Oxohygrolidin; 98813-11-7; (3E,5E,7R,8S,9S,11E,13E,15S,16R)-16-[(E,2S,3R,4S,8R,9R)-3,9-dihydroxy-4,8-dimethyl-5-oxoundec-6-en-2-yl]-8-hydroxy-15-methoxy-3,5,7,9,11-pentamethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one
CAS NA
PubChem CID 101421469
ChEMBL ID NA
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Phenylpropanoids and poly
      • Class: Macrolides and analogues
        • Subclass: No Rank at Level Subclass
          • Direct Parent: Macrolides and analogues

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte IDEndophyte NameFamilyGenusTaxonomy IDGenBank IDClosest GenBank IDReference
Endophyte ID
Endophyte Name
Family
Genus
Taxonomy ID
GenBank ID
Closest GenBank ID
Reference
Endophyte ID
Endophyte Name
Family
Genus
Taxonomy ID
GenBank ID
Closest GenBank ID
Reference
Loading...
Endophyte IDEndophyte NameFamilyGenusTaxonomy IDGenBank IDClosest GenBank IDReference
Showing 0 to 0 of 0 entries

NPs Physi-Chem Properties

Molecular Weight: 574.8 ALogp: 5.6
HBD: 3 HBA: 7
Rotatable Bonds: 9 Lipinski's rule of five: Rejected
Polar Surface Area: 113.0 Aromatic Rings: 1
Heavy Atoms: 41 QED Weighted: 0.239

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.736 MDCK Permeability: 0.00001360
Pgp-inhibitor: 0.998 Pgp-substrate: 0.993
Human Intestinal Absorption (HIA): 0.833 20% Bioavailability (F20%): 0.41
30% Bioavailability (F30%): 0.727

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.015 Plasma Protein Binding (PPB): 92.75%
Volume Distribution (VD): 2.376 Fu: 4.41%

ADMET: Metabolism

CYP1A2-inhibitor: 0.052 CYP1A2-substrate: 0.571
CYP2C19-inhibitor: 0.065 CYP2C19-substrate: 0.902
CYP2C9-inhibitor: 0.186 CYP2C9-substrate: 0.442
CYP2D6-inhibitor: 0.095 CYP2D6-substrate: 0.673
CYP3A4-inhibitor: 0.936 CYP3A4-substrate: 0.479

ADMET: Excretion

Clearance (CL): 8.294 Half-life (T1/2): 0.333

ADMET: Toxicity

hERG Blockers: 0.266 Human Hepatotoxicity (H-HT): 0.966
Drug-inuced Liver Injury (DILI): 0.578 AMES Toxicity: 0.013
Rat Oral Acute Toxicity: 0.116 Maximum Recommended Daily Dose: 0.891
Skin Sensitization: 0.537 Carcinogencity: 0.054
Eye Corrosion: 0.004 Eye Irritation: 0.013
Respiratory Toxicity: 0.665
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

*Note: the compound similarity was calculated by RDKIT.